Octagon Capital Advisors LP: 13F holdings
CIK 18394352026Q2
| Positions | 27 |
|---|
| Reported value | $1.1bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 27 (-2 vs prior quarter) |
|---|
| Reported value | $1.1bn (+23.1%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| DNTH DIANTHUS THERAPEUTICS INC | 1,841,667 | $179.5m | 16.1% |
| DFTX DEFINIUM THERAPEUTICS INC | 2,950,000 | $138.8m | 12.5% |
| ABVX ABIVAX SA | 993,000 | $132.3m | 11.9% |
| COGT COGENT BIOSCIENCES INC | 2,350,000 | $90.9m | 8.2% |
| ALMS ALUMIS INC | 2,830,700 | $79.7m | 7.2% |
| AVBP ARRIVENT BIOPHARMA INC | 1,971,054 | $68.5m | 6.2% |
| TSHA TAYSHA GENE THERAPIES INC | 9,693,244 | $66.0m | 5.9% |
| BIOA BIOAGE LABS INC | 1,748,000 | $42.8m | 3.9% |
| MIRM MIRUM PHARMACEUTICALS INC | 338,900 | $39.7m | 3.6% |
| KYMR KYMERA THERAPEUTICS INC | 310,000 | $35.5m | 3.2% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1839435")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples